 | -$0.28 Earnings Per Share Expected for Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) This Quarter
americanbankingnews.com - April 12 at 10:28 AM |
 | Royalty Pharma Buys Dicerna's Royalty Interest In OXLUMO
markets.businessinsider.com - April 8 at 9:02 AM |
 | Royalty Pharma Acquires OXLUMO™ Royalty Interest From Dicerna for up to $240 Million
finance.yahoo.com - April 8 at 9:02 AM |
| Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) Insider Regina M. Paglia Sells 4,431 Shares
americanbankingnews.com - April 5 at 11:28 PM |
| Bob D. Brown Sells 8,312 Shares of Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) Stock
americanbankingnews.com - April 5 at 10:42 PM |
| Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) Given Consensus Recommendation of "Buy" by Analysts
americanbankingnews.com - April 1 at 10:32 AM |
| Dicerna’s GalXC-Plus™ RNAi Technology Delivers Target Knockdown Across CNS and to Specific CNS Cell Types in Preclinical Studies
finance.yahoo.com - March 30 at 1:29 PM |
| Dicerna to Present New GalXC-Plus™ Nonclinical CNS Data at Oligonucleotide and Precision Therapeutics Virtual Congress
finance.yahoo.com - March 24 at 8:53 AM |
 | First Week of May 21st Options Trading For Dicerna Pharmaceuticals (DRNA)
nasdaq.com - March 19 at 3:07 PM |
| Dicerna Pharmaceuticals (NASDAQ:DRNA) Stock Price Down 7.8%
americanbankingnews.com - March 18 at 8:34 PM |
|
| Dicerna to Host Webinar on DCR-AUD Alcohol Use Disorder Candidate on March 18, 2021
finance.yahoo.com - March 11 at 7:33 AM |
| What You Need To Know About Dicerna Pharmaceuticals, Inc.'s (NASDAQ:DRNA) Investor Composition
finance.yahoo.com - March 7 at 12:21 PM |
 | Dicerna and Roche start mid-stage Hepatitis B RG6346 trial
seekingalpha.com - March 5 at 1:01 PM |
| Dicerna Announces Roche’s Initiation of GalXC™ RNAi Candidate RG6346 in Phase 2 Combination Trial for Treatment of Chronic Hepatitis B Virus Infection
finance.yahoo.com - March 4 at 11:57 AM |
| Recap: Dicerna Pharmaceuticals Q4 Earnings
finance.yahoo.com - February 25 at 11:55 PM |
| Dicerna Announces Full Year 2020 Financial Results and Provides a Business Update
finance.yahoo.com - February 25 at 6:54 PM |
| Dicerna to Report Full Year 2020 Financial Results on Feb. 25, 2021
finance.yahoo.com - February 18 at 12:55 PM |
| Dicerna Starts Dosing With Nedosiran In Primary Hyperoxaluria Early-Stage Study
markets.businessinsider.com - February 11 at 1:50 PM |
| Dicerna Initiates PHYOX™4 Trial of Nedosiran for Primary Hyperoxaluria Type 3
finance.yahoo.com - February 11 at 8:49 AM |
| Novo Nordisk selects first development candidate under Dicerna pact
seekingalpha.com - January 7 at 3:15 PM |
| Should You Take Comfort From Insider Transactions At Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA)?
finance.yahoo.com - January 6 at 1:11 PM |
| Dicerna Announces Novo Nordisk’s Nomination of First Candidate for Development Under RNAi Discovery and Development Agreement and Additional Milestone Achievement
finance.yahoo.com - January 5 at 9:26 AM |
| Is the Options Market Predicting a Spike in Dicerna (DRNA) Stock?
finance.yahoo.com - December 22 at 2:46 PM |
| Is DRNA A Good Stock To Buy Now According To Hedge Funds?
finance.yahoo.com - December 20 at 5:05 PM |
| First Week of DRNA February 2021 Options Trading
nasdaq.com - December 18 at 3:12 PM |
| Dicerna: Great Value RNAi Runner Up
seekingalpha.com - December 17 at 8:46 AM |
| Is Dicerna Pharmaceuticals (DRNA) a Smart Long-term Buy?
finance.yahoo.com - December 11 at 1:30 PM |
| Dicerna Pharmaceuticals Inc Outperform
markets.businessinsider.com - November 27 at 12:29 AM |
| Dicerna/Roche's hepatitis B candidate shows durable effect in early-stage study
seekingalpha.com - November 16 at 6:40 PM |
 | Dicerna Announces Positive Updated Data From Phase 1 Trial of RG6346 for Treatment of Chronic Hepatitis B Virus (HBV) Infection at AASLD’s The Liver Meeting ® Digital ...
businesswire.com - November 16 at 1:39 PM |
|
| Dicerna Announces FDA Acceptance of Lilly’s Investigational New Drug (IND) Application for First GalXC™ RNAi Candidate Under Companies’ Global Research Collaboration and ...
businesswire.com - November 16 at 8:38 AM |
| Dicerna Announces FDA Acceptance of Lilly’s Investigational New Drug (IND) Application for First GalXC™ RNAi Candidate Under Companies’ Global Research Collaboration and Licensing Agreement
finance.yahoo.com - November 16 at 8:38 AM |
| Dicerna Announces Positive Updated Data From Phase 1 Trial of RG6346 for Treatment of Chronic Hepatitis B Virus (HBV) Infection at AASLD’s The Liver Meeting® Digital Experience™ 2020
finance.yahoo.com - November 16 at 8:38 AM |
| Dicerna to Participate in Upcoming Investor Conferences
finance.yahoo.com - November 11 at 8:22 PM |
| Dicerna Presents New Nonclinical Research Highlighting the Application of its RNAi Technology in Extrahepatic Tissues at TIDES Europe 2020
finance.yahoo.com - November 10 at 6:40 PM |
| Was The Smart Money Wrong About Piling Into Dicerna Pharmaceuticals Inc (DRNA)?
finance.yahoo.com - November 9 at 5:33 PM |
| Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) Reported Earnings Last Week And Analysts Are Already Upgrading Their Estimates
nasdaq.com - November 7 at 1:04 PM |
| Earnings Update: Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) Just Reported And Analysts Are Boosting Their Estimates
finance.yahoo.com - November 7 at 1:04 PM |
| Dicerna Pharmaceuticals Inc (DRNA) Q3 2020 Earnings Call Transcript
finance.yahoo.com - November 6 at 2:37 PM |
| Dicerna Pharmaceuticals EPS misses by $0.05, misses on revenue
seekingalpha.com - November 5 at 6:31 PM |
| Dicerna Pharmaceuticals, Inc. to Host Earnings Call
finance.yahoo.com - November 5 at 6:31 PM |
| Dicerna Announces Third Quarter 2020 Financial Results and Provides a Business Update
finance.yahoo.com - November 5 at 6:31 PM |
| Dicerna Announces Updated Phase 1 Data on RG6346 Investigational Treatment for Chronic Hepatitis B Virus to be Presented in Late-Breaking Session at AASLD’s The Liver Meeting® Digital Experience™ 2020
finance.yahoo.com - November 1 at 5:02 PM |
| Will Dicerna Pharmaceuticals (DRNA) Report Negative Q3 Earnings? What You Should Know
finance.yahoo.com - October 29 at 6:07 PM |
| Dicerna to Report Third Quarter 2020 Financial Results on November 5, 2020
finance.yahoo.com - October 29 at 6:07 PM |
| Dicerna's nedosiran shows positive effect in rare kidney stone disorder
seekingalpha.com - October 22 at 12:42 PM |
| Dicerna Presents Positive New Interim Data From PHYOX™3 Long-Term, Open-Label Extension Study of Nedosiran for Treatment of Primary Hyperoxaluria (PH)
finance.yahoo.com - October 22 at 12:42 PM |
| Dicerna Appoints Ling Zeng as Chief Legal Officer and Secretary
finance.yahoo.com - September 16 at 10:34 AM |
| Dicerna Pharmaceuticals Inc (DRNA) President and CEO Douglas Fambrough Bought $180,600 of Shares
finance.yahoo.com - September 2 at 12:36 AM |
| Dicerna's hepatitis B drug shows encouraging effect in early-stage study
seekingalpha.com - August 6 at 5:24 PM |
